How to write drug alerts in the US - tips from the FDA
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued advice to drug manufacturers on the best way to write “Dear Health Care Provider Letters” in an effort to improve the effectiveness of such communication.